TMV painting detail 1


October 2010

Total Scientific Expands into New Premises

Total Scientific, a CRO specialising in biomarkers, has moved into custom-designed units in the new Maia building at Babraham Research Campus, marking the latest stage in its expansion.
full article/close article >

January 2010

FX125L Phase I programme completed

Our portfolio company Funxional Therapeutics today announced the successful completion of the Phase I programme for its lead molecule, the broad-spectrum chemokine inhibitor FX125L.
full article/close article >

March 2008

PRONOSTICS signs distribution agreement with MEDIPAN GmbH to sell its lead products in Europe’s largest diagnostics market

full article/close article >

Feb 2008

Konstantinos Efthymiopoulos joins as CEO of Funxional Therapeutics

Funxional Therapeutics Ltd today announced that Konstantinos Efthymiopoulos has joined the company as Chief Executive Officer, replacing Jason Avery who left at the end of October 2007.
full article/close article >